News Story: Full Text
Sponsored By
Gleolan for brain tumors
Please Click On The Above Banner For More Details
Braintumor Website

 

"National Cancer Comprehensive Network" adds "alternating electric field therapy" (Novocure) to it`s treatment guidelines for treatment of recurrent glioblastoma

Al's Comment:

 The NCCN guidelines are important because many insurance plans base their payment decisions upon these guidelines! The new version lists  "alternating electric field therapy" (Novocure TTF100-A is the only FDA approved alternating electric field therapy device) as an option for both local or multiple/diffuse recurrences of GBMs.

 


Posted on: 01/09/2013

To view the guidelines, go to:

www.nccn.org/professionals/physician_gls/pdf/cns.pdf

A free registration is required

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740